c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
ESAIY
EISAI CO LTD U/ADR
stock
OTC
ADR
EOD
Nov 18, 2026
8.10
USD
-1.220%
(-0.10)
36,963
Pre-market
After-hours
Overview
Company
Exchanges
Shorts
News
News
ESAIY News
1
/
1
Nov 10, 2026
Day breaks
Nov 13, 2026
10:15 AM EST
LEQEMBI(R) Pen (Subcutaneous Formulation of LEQEMBI(R)) Now Available in Japan for Patients with Early Alzheimer's Disease
·
JCN Newswire
Nov 10, 2026
09:05 AM EST
Eisai Co., Ltd. (ESAIY) Q2 2027 Earnings Call Transcript
·
Seeking Alpha
09:04 AM EST
Eisai Advances Initiatives to Support Dietary Behavior Change Aimed at Reducing the Risk of Cognitive Decline
·
JCN Newswire
02:19 AM EST
Eisai GAAP EPS of ¥106.18, revenue of ¥470B; progressing toward ¥883.5B FY26 forecast
·
Seeking Alpha
Nov 1, 2026
08:29 AM EST
Eisai to Present New Five-Year Lecanemab Data and Real-World Alzheimer's Disease Research at the 19th Clinical Trials on Alzheimer's Disease (CTAD) Conference
·
JCN Newswire
Oct 28, 2026
07:04 AM EDT
Biogen boosts outlook after Q3 beat on multiple sclerosis franchise
·
Seeking Alpha
Oct 16, 2026
11:31 AM EDT
Eisai Deepens Its Oncology Evidence Base at ESMO Congress 2026
·
JCN Newswire